Klinische und molekularzytogenetische Charakterisierung von AesthesioneuroblastomenXuejun You21.51.1.61.2.7423#44681.3.9102.113.123.1.1314340#256473#3613.2.1516171819527#38120591#56121448#264593#3164.224.1.23603#32824604#79125585#4354.2.2627586#385284.3.29586#34430547#88331589#91232576#90933561#333586#3445.345.1.35586#30836375.2.383940415.3.426.434445LITERATURVERZEICHNIS464748495051 ANHANG52604#801 Abkürzungsverzeichnis5354Lebenslauf5556Eidesstattliche Erklärung57DANKSAGUNGdeInhaltsverzeichnisHilfe LITERATURVERZEICHNIS Åkervall JA, Michaelides RJAM, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , Cancer 1997 :79:380-389 Baron SH: Brain radiation necrosis following treatment of an esthesioneuroblastoma (olfactory neurozytoma), Laryngoscope 1979:89:214-223 Berger L, Luc R, Richard J: L ' esthesioneuroepitheliome olfactif, Bull Assoc Fr etude Cancer 1924:13:410-421 Berghaus A, Jovanovic S: Technique and indications of extended sublabial rhinotomy ("midfacial degloving"), Rhinology. 1991 :29:105-110 Biller HF, Lawson W, Lachdev V, Som P: Esthesioneuroblastoma: surgical treatment without radiation, Laryngoscope 1990:100:1199-1201 Bilsky MH, Kraus DH, Strong EW, Harrison LB, Gutin PH, Shah JP: Extended anterior craniofacial resection for intracranial extension of malignant tumors, Am. J. Surg. 1997: 174:565-568 Bissig H, Richter J, Desper R, Meier V, Schraml P, Schaffer AA, Sauter G, Mihatsch MJ, Moch H: Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization, Am J. Pathol. 1999:155:267-274 Bockmühl U: Molekularzytogenetische Charakterisierung von Plattenepithelkarzinomen des Kopf-Hals-Bereiches, Laryngol. Rhinol. Otol. 2000b:79:249-250 Bockmühl U, Ishwad CS, Ferrell RE, Gollin SM: Association of 8p23 deletions with poor survival in head and neck cancer, Otolaryngol. Head Neck Surg. 2001:124:451-455 Bockmühl U, Petersen I, Schwendel A, Dietel M: Genetisches Screening von Kopf-Hals-Karzinomen mittels der Komparativen Genomischen Hybridisierung (CGH). Laryngol. Rhinol. Otol., 1996b:75: 408-414 Bockmühl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, Petersen I : Patterns of chromosomal alterations in metastasizing and non metastasizing primary head and neck cancinomas, Cancer Res. 1997:57:5213-5216 Bockmühl U, Schlüns K, Küchler I, Petersen S, Petersen I: Genetic imbalances with impact on survival in head and neck cancer patients, Am J Pathol 2000a:157:369-375 Bockmühl U, Schlüns K, Schmidt S, Matthias S, Petersen I: Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma , Genes Chromosom. Cancer 2002 :33:29-35 Bockmühl U, Schwendel A, Dietel M, Petersen I: Distinct patterns of chromosomal alterations in high and low grade head and neck squamous cell carcinomas, Cancer Res. 1996a:56:5325-5329 Bockmühl U, Wolf G, Schmidt S, Schwendel A, Jahnke V, Dietel M, Petersen I: Genomic alterations associated with malignancy in head and neck cancer, Head Neck 1998:20:145-151 Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Böcker W, Störkel S: Synopse unbalancierter chromosomaler Aberrationen beim Neuroblastom durch komparative genomische Hybridisierung (CGH), Pathologe 1996:17:368-373 Broich G, Pagliari A, Ottaviani F: Esthesioneuroblastoma: a general rewiew of the cases published since the discovery of the tumor in 1924, Anticancer-Res. 1997:17(4A):2683-2706 Cantrell RW, Ghorayet BY, Fitz-Hugh GS: Esthesioneuroblastoma. Diagnosis and treatment , Ann. Otol. 1977:86:760-765 Chapman P, Carter RL, Clifford P: The diagnosis and surgical management of olfactory neuroblastoma: the role of craniofacial resection. J. Laryngol. Otol. 1981:95:785-799 Christiansen H, Lampert F: Tumorcytogenetik und Prognose beim Neuroblastom, Monatsschr. Kinderheilkd. 1989:137:666-671 Caron H: Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma, Med. Pediatr. Oncol. 1995:24:215-221 Davis RE, Weissler MC: Esthesioneuroblastoma and neck metastasis, Head Neck 1992:14:477-482 Devoe K, Weidner N: Immunohistochemistry of small round-cell tumors, Semin. Diagn. Pathol. 2000:17(3):216-224 Donald PJ: Frontobasal approach for trauma and tumor. Minim. Invasive Neurosurg. 1994:37:37-41 Doyle PJ, Payton HD: Combined surgical approach to esthesioneuroblastoma, Trans. Pa. Acad. Ophthalmol. Otolaryngol. 1971:75:526-531 Draf W, Berghaus A: Tumoren und Pseudotumoren („tumorähnliche Läsionen“) der frontalen Schädelbasis, ausgehend von der Nase, den Nasennebenhöhlen und dem Nasenrachenraum (einschliesslich der operativen Zugänge). Rhinochirurgisches Referat, Eur. Arch. Otorhinolaryngol. 1993:1(Suppl):105-18 Draf W, Samii M: Surgical treatment of malignant tumors of the paranasal sinuses with involvement of the base of the skull, Strahlenther. Onkol. 1989 :165:474-477 Draf W, Schauss F: External rhinoplasty: its role in aesthetic and functional surgery of the nose, Facial Plast. Surg. 1995:11:228-236 Dulguerov P, Calcaterra T: Esthesioneuroblastoma: the UCLA experience 1970-1990, Laryngoscope 1992:102: 843-849 du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T: Detection of complete and partial chromosome gain and losses by comparative genomic hybridization, Hum. Genet. 1993:90:590-610 Duesberg P, Rasnick D: Aneuploidy, the somatic mutation that makes cancer a species of its own, Cell Motil. Cytoskelet. 2000:47:81-107 Eden BV, Debo RF, Larner JM, Kelly MD, Levine PA, Stewart FM, Cantrell RW, Constable WC: Esthesioneuroblastoma: Long-term outcome and patterns of failure – the University of Virginia experience, Cancer 1994 :73:2556-2562 Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC: Esthesioneuroblastoma, Cancer 1979:44:1087-1094 Eriksen JG, Bastholt L, Krogdahl AS, Hansen O, Joergensen KE: Esthesioneuroblastoma: what is the optimal treatment? Acta Oncologica 2000:39:231-235 Feyerabend T: Die Stellung der Radiotherapie in der Behandlung des Ästhesioneuroblastoms, HNO 1990 :38:20-23 Girgert R, Treuner J, Schweizer P: Molekularbiologische Merkmale des Neuroblastoms als Grundlage eines Therapiekonzepts, Langenbecks Arch. Chir. Suppl II (Kongressbericht 1996) 1996:1053-1055 Gronwald J, Störkel S, Holtgreve-Grez H, Hdaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T: Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: Importance of 1q and 3p copy number changes in metastatic events, Cancer Res. 1997:57:481-487 Hanahan D, Weinberg RA: The hallmarks of cancer, Cell 2000:100:57-70 Hirose T, Scheithauer BW, Lopes M.BS, Gerber HA, Altermatt HJ, Harner SG, Vandenberg SR: Olfactory neuroblastoma, an immunohistochemical, ultrastructural, and flow cytometric study, Cancer 1995:76(1):4-19 Homize MJ, Elkon D: Olfactory esthesioneuroblastoma – variables predictive of tumor control and recurrence, Cancer 1980:46:2509-2513 Hyams VJ: Olfactory neuroblastoma (case 6). In: Batsakis JG, Hyams VJ, Moralea AR. Special Tumors of the Head and Neck. Chicago: American Society of Clinical Pathologists, 1983:24-29 Irish J, Freeman J, Gullane P, Gentili F, Brown D, Neligan P, O٬Sullivan B: Outcome and analysis of the surgical management of esthesioneuroblastoma, J. Otolaryngol. 1997:26:1-7 sola JI, Kallioniemi OP, Chu LW, Fuqua SAW, Hilsenbeck SG, Osborne CK, Waldman FM: Genetic aberration detected by Comparative Genomic Hybridization predict outcome in node-negative breast cancer, Am. J. Pathol. 1995 :147:905-911 Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma: a clinical analysis of 17 cases, Cancer 1976:37: 1571-1576 Kairemo KJ, Jekunen AP, Kestila MS, Ramsay HA: Imaging of olfactory neuroblastoma – an analysis of 17 cases, Auris-Nasus-Larynx 1998:25:173-179 Kallioniemi A., Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparativ genomic hybridization. Proc. Natl. Acad. Sci. USA 1994b :91:2156-2160 Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992:258:818-821 Kallioniemi A., Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom. Cancer 1994a:10: 231-234 Kempf H-G, Becker G, Weber BP, Ruck P: Diagnostik und Therapie des Olfaktoriusneuroblastoms, HNO 1994:42:422-428 Kuukasjärvi T, Karhu R, tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer, Cancer res. 1997:57:1597-1604 Levin NA, Broszka P, Warnock ML, Gray JW, Christman MF: Identification of novel regions of altered DNA copy number in small cell lung tumors, Genes Chromosom. Cancer 1995:13:175-185 Levine PA, Debo RF, Meredith SD, Jane JA, Constable WC, Cantrell RW: Craniofacial resection at the University of Virginia (1976-1992): survival analysis. Head Neck 1994:16:574-577 Levine PA, Gallagher R, Canntrell RW: Esthesioneuroblastoma: reflections of a 21-years experience, Laryngoscope 1999:109:1539-1543 Lewis JS, Hutter R, Tollefsen HR, Foot F: Nasal tumors of olfactory origin, Arch. Otolaryngol. 1965:81:169-173 Li J, Yen C, Liaw D, Podsypania K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science 1997:275:1943-1947 Lund VJ, Milroy C: Olfactory neuroblastoma: clinical and pathological aspects, Rhinology 1993:31(1):1-6 Miyamoto RC, Gleich LL, Biddinger W, Gluckman JL: Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis, Laryngoscope 2000:110:1262-1265 Moch H, Presti, Jr JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM: Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma, Cancer Res. 1996:56:27-30 Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wigenbus KK, von Deimling A, Poustka A: DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors, Nature Genet. 1997: 17:32-39 Morita A, Ebersold MJ, Oslen KD, Foote R:L, Lewis JE, Quast LM: Esthesioneuroblastoma: Prognosis and Management, Neurosurgery 1993:32:706-715 Moure EI: Technique chirurgicale oto-rhino-laryngologique. Premier fascicule, L’oreille et ses anexes, Libraire Octave Dein,

Paris

, 1922 Obermann HA, Rice DH: Olfactory neuroblastomas: a clinicopathologic study, Cancer 1976:38:2494-2502 O٬Connor TA, McLean P, Juillard GJF, Parker RG: Olfactory neuroblastoma, Cancer 1989:63:2426-2428 Papadaki H, Kounelis S, Kapadia SB, Bakker A, Swalsky PA, Finkelstein SD: Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma, Am. J. Surg. Pathol. 1996:20 (6): 715-721 Parsons JT, Mendenhall WM, Mancuso AA, Cassisi NJ, Million RR : Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses, Int.J. Radiat. Oncol. Biol. Phys. 1988: 14: 11-22 Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T: Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung, Cancer Res. 1997:a :57: 2331-2335 Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel M, Ried T, Dietel M: Small cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p, Br. J. Cancer 1997b :75: 79-86 Petersen I, Schwendel A, Bockmühl U, Dietel M: Die Komparative Genomische Hybridisierung: Eine Screeningmethode in der genetischen Tumordiagnostik. Pathologe, 1996:17: 333-341 Petersen S, Wolf G, Bockmühl U, Gellert M, Dietel M, Petersen I : Allelic loss on chromosome 10q in human lung cancer: association with tumor progression and metastatic phenotype , Br. J. Cancer 1998 :77:270-276 Ranjan D, Hennessy RG: Esthesioneuroblastoma: cerebral and spinal metastases without direct cranial invasion, J. Neurooncol. 1986 :4: 71-74. Raveh J, Laedrach K, Speiser M, Chen J, Vuillemin T, Seiler R, Ebeling U, Leibinger K: The subcranial approach for fronto-orbital and anteroposterior skull-base tumors. Arch. Otolaryngol. Head Neck Surg. 1993:119:385-93. Reichel MB, Ohgaki H, Petersen I, Kleihues P: p53 mutations in primary human lung tumors and their metastases, Mol. Carcinog. 1993 :139-143 Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee D-L, Westra WH : Esthesioneuroblastoma: the Johns Hopkins experience, Head Neck 2000 :22: 550-558 Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, du Manoir S, Cremer T: Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization, Cancer Res. 1994 :54: 1801-1806 Roth K, Wolf G, Dietel M, Petersen I: Image analysis for Comparative genomic Hybridization based on a karyotyping program for Windows. Anal. Quant. Cytol. Histol. 1997:19:461-474 Sambrook J, Fritsch EF, Maniatis T: Molekular Cloning: A Laboratory Manual. 2. Auflage, Cold Spring Harbor Laboratory,

New

York

, 1989 Samii M, Draf W: Surgery of the Skull Base.

Heidelberg, Berlin, New York

: Springer, 1989 Schmidt JL, Zarbo RJ, Clark JL: Olfactory neuroblastoma: Clinico-pathologic and immunohistochemical characterization of four representative cases, Laryngoscope 1990:100:1052-1058 Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nürnberg P, Vogel S, Jänisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T: Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses, Am. J. Pathol. 1994:144:1203-1218 Schuster V, Kreth HW: Molekularbiologische Aspekte des Neuroblastoms, Monatsschr. Kinderheilkd. 1987:135:672-676 Schwendel A, Langreck H, Reichel M, Schröck E, Ried T, Dietel M, Petersen I: Primary small cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations, Int. J. Cancer 1997:74:86-93 Simon JH, Zhen WN, McCulloch TM, Hoffman HT, Paulino AC, Mayr NA, Buatti JM: Esthesioneuroblastoma: the University of Iowa experience 1978-1998, Laryngoscope 2001:111:488-493 Smith RR, Klopp CT, Williams JM: Surgical treatment of cancer of the frontal sinus and adjacent areas, Cancer 1954:7: 991-994 Spaulding CA, Kranyak MS, Constable WC, Stewart FM: Esthesioneuroblastoma: a comparison of two treatment eras, Int. J. Radiat. Oncol. Biol. Phys. 1988:15:581-590 Speicher MR, du Manoir S, Schröck E, Holtgreve-Grez H, Schoell B, Lengauer C, Cremer T, Ried T: Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification, Hum. Mol. Genet. 1993 :2: 1907-1914 Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigan SV: Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , Nature Genet. 1997:15:356-362 Szymas J, Wolf G, Kowalczyk D, Nowak S, Petersen I : Olfactory neuroblastoma: Detection of genomic imbalances by comparative genomic hybridization, Acta Neurochir. (

Wien

) 1997:139:839-844 van Dyke D, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE: Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region, Genes Chromosom. Cancer 1994 :9: 192-206 Verma RS, Babu A: Human Chromosomes: Principles and Techniques. 2. Auflage, McGrraw-Hill,

New York

, 1994 Vollrath M: Chemically induced esthesioneuroepithelioma: a cytogenetic, cell culture and biochemical investigation with implications for tumor histogenesis , Arch. Otorhinolaryngol. 1989:246:71-78 Walch C, Stammberger H, Unger F, Angerhuber W: Ein neues Therapiekonzept bei Ästhesioneuroblastom, Laryngol. Rhinol. Otol. 2000:79:743-748 Weber R, Keerl R, Draf W, Schick B, Mosler P, Saha A: Management of dural lesions occurring during endonasal sinus surgery. Arch. Otolaryngol. Head Neck Surg. 1996:122:732-736. Weber R, Sabel M, Reifenberger J, Sommer C, Oberstraß J, Reifenberger G, Kiessling M, Cremer T: Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization, Oncogene 1996:12:983-994 Wick MR, Stamley SJ: Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and anti-synaptophysin, Arch. Pathol. Lab. Med. 1988:112:616-620 Wright K, Manos MM: PCR Protocols: A guide to methods and amplications. Academic Press Inc., 1990:153-158 Zappia JJ, Caroll WR, Wolf GT, Thornton AT, Ho L, Krause CJ: Olfactory neuroblastoma: the results of modern treatment approaches at the University of Michigan, Head Neck 1993:15:190-196 Zumegen C, Michel O: Problematik der Klassifikation und Prognose des Aesthsioneuroblastoms anhand von sieben therapierten Fällen, Laryngol. Rhinol. Otol. 2000:79:736-742